BeOne Medicines
ONC
#668
Rank
โ‚น3.301 T
Marketcap
โ‚น28,742
Share price
3.86%
Change (1 day)
23.81%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): โ‚น59.27

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is โ‚น60.57. In 2024 the company made an earnings per share (EPS) of -โ‚น581.48.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น59.27-110.19%
2024-โ‚น581.48
2022-โ‚น1,80527.35%
2021-โ‚น1,417-19.96%
2020-โ‚น1,77120.81%
2019-โ‚น1,46631.52%
2018-โ‚น1,115417.57%
2017-โ‚น215.34-37.16%
2016-โ‚น342.70158.95%
2015-โ‚น132.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น22.36-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น88.53-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA